Integrity Laboratories has completed the validation for the Monkeypox virus PCR test. The test is now available for immediate order by clinicians. 

“We are pleased to lead the infectious diseases field once again in the timely validation and availability of this addition to the LesionDx menu using our laboratory developed testing algorithm,” says Christian Clevenger, CEO at Integrity Laboratories.

According to the Center for Disease Control, the Monkeypox virus can be spread via direct skin-to-skin contact as well as respiratory secretions1. The possibility of transmission from those who have yet to display symptoms is still unknown, therefore timely and accurate testing remains critical.

“The sensitivity for detection of the Monkeypox virus by Integrity Laboratory’s assay is 10cp/uL with 100% specificity,” says Clevenger. “We are pleased to provide highly accurate results for incoming specimens within 24-48 hours of receipt. Our DNA-based PCR platform uses the proprietary Intercept PCR platform to identify a growing number of viral and bacterial infectious disease targets for women’s health, wound care, gastrointestinal, respiratory, and wound management.”

Integrity Laboratories is healthcare technology organization with a focus on precision medicine through molecular diagnostics. The company’s singular purpose is to enable clinicians, through advanced technologies, to improve patient outcomes while lowering total costs of healthcare delivery. Integrity Laboratories partners with trusted providers, healthcare systems, and payer networks to improve healthcare for all through high complexity, rapid, clinical diagnostics.